Structural characteristics of HLA-DQ that may impact DM editing and susceptibility to type-1 diabetes

Frontiers in Immunology

Volumn 4, Issue AUG, 2013, Pages

  Zhou, Zemin ^a   Jensen, Peter E ^a  

^a ARUP LABORATORIES   (United States)

Author keywords

Autoreactive T cells; HLA DM; HLA DQ; Invariant chain; Negative selection; Type 1 diabetes

Indexed keywords

CLASS II ASSOCIATED II PEPTIDE; HLA DM ANTIGEN; HLA DQ ANTIGEN; HLA DQ1 ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CROSS REACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR BIOLOGY; NONHUMAN; PEPTIDE EDITING; T LYMPHOCYTE;

EID: 84883735387     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00262     Document Type: Article

References (51)

1. Gorodezky C, Alaez C, Murguia A, Rodriguez A, Balladares S, Vazquez M, et al. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun Rev (2006) 5:187-94. doi:10.1016/j.autrev.2005.06.002
2. Cifuentes RA, Rojas-Villarraga A, Anaya JM. Human leukocyte antigen class II and type 1 diabetes in Latin America: a combined meta-analysis of association and family-based studies. Hum Immunol (2011) 72:581-6. doi:10.1016/j.humimm.2011.03.012
3. Rojas-Villarraga A, Botello-Corzo D, Anaya JM. HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun Rev (2010) 9:666-73. doi:10.1016/j.autrev.2010.05.016
4. Ge X, Piganelli JD, Tse HM, Bertera S, Mathews CE, Trucco M, et al. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility. Diabetes (2006) 55:3455-62. doi:10.2337/db06-0680
5. Geenen V, Louis C, Martens H. An insulin-like growth factor 2-derived self-antigen inducing a regulatory cytokine profile after presentation to peripheral blood mononuclear cells from DQ8+ type 1 diabetic adolescents: preliminary design of a thymus-based tolerogenic self-vaccination. Ann N Y Acad Sci (2004) 1037:59-64. doi:10.1196/annals.1337.008
6. Liu J, Purdy LE, Rabinovitch S, Jevnikar AM, Elliott JF. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes (1999) 48:469-77. doi:10.2337/diabetes.48.3.469
7. Mallone R, Brezar V, Boitard C. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives. Clin Dev Immunol (2011) 2011:513210. doi:10.1155/2011/513210
8. van Lummel M, van Veelen PA, Zaldumbide A, de Ru A, Janssen GM, Moustakas AK, et al. Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem (2012) 287:9514-24. doi:10.1074/jbc.M111.313940
9. van Autreve JE, Weets I, Gulbis B, Vertongen F, Gorus FK, van der Auwera BJ, et al. The rare HLA-DQA1*03-DQB1*02 haplotype confers susceptibility to type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects. Hum Immunol (2004) 65:729-36. doi:10.1016/j.humimm.2004.04.004
10. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A (2006) 103:14074-9. doi:10.1073/pnas.0606349103
11. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes (2008) 57:1084-92. doi:10.2337/db07-1331
12. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol (2011) 11:823-36. doi:10.1038/nri3084
13. O'Brien C, Flower DR, Feighery C. Peptide length significantly influences in vitro affinity for MHC class II molecules. Immunome Res (2008) 4:6. doi:10.1186/1745-7580-4-6
14. Jensen PE. Recent advances in antigen processing and presentation. Nat Immunol (2007) 8:1041-8. doi:10.1038/ni1516
15. Narayan K, Chou CL, Kim A, Hartman IZ, Dalai S, Khoruzhenko S, et al. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat Immunol (2007) 8:92-100. doi:10.1038/ni1414
16. Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science (1996) 274:618-20. doi:10.1126/science.274.5287.618
17. Ferrante A, Gorski J. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond. J Immunol (2010) 184:1153-8. doi:10.4049/jimmunol.0902878
18. Zhou Z, Callaway KA, Weber DA, Jensen PE. Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes. J Immunol (2009) 183:4187-91. doi:10.4049/jimmunol.0901663
19. Denzin LK, Hammond C, Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med (1996) 184:2153-65. doi:10.1084/jem.184.6.2153
20. Grotenbreg GM, Nicholson MJ, Fowler KD, Wilbuer K, Octavio L, Yang M, et al. Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association. J Biol Chem (2007) 282:21425-36. doi:10.1074/jbc.M702844200
21. Anders AK, Call MJ, Schulze MS, Fowler KD, Schubert DA, Seth NP, et al. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol (2011) 12:54-61. doi:10.1038/ni.1967
22. Painter CA, Cruz A, Lopez GE, Stern LJ, Zavala-Ruiz Z. Model for the peptide-free conformation of class II MHC proteins. PLoS ONE (2008) 3:e2403. doi:10.1371/journal.pone.0002403
23. Rupp B, Gunther S, Makhmoor T, Schlundt A, Dickhaut K, Gupta S, et al. Characterization of structural features controlling the receptiveness of empty class II MHC molecules. PLoS ONE (2011) 6:e18662. doi:10.1371/journal.pone.0018662
24. Yaneva R, Springer S, Zacharias M. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study. Biopolymers (2009) 91:14-27. doi:10.1002/bip.21078
25. Pos W, Sethi DK, Call MJ, Schulze MS, Anders AK, Pyrdol J, et al. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell (2012) 151:1557-68. doi:10.1016/j.cell.2012.11.025
26. Guce AI, Mortimer SE, Yoon T, Painter CA, Jiang W, Mellins ED, et al. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol (2013) 20:90-8. doi:10.1038/nsmb.2460
27. Cucchi-Mouillot P, Lai S, Carcassi C, Sorba P, Stuart-Simoni M, Amoros JP, et al. Implication of HLA-DMA alleles in corsican IDDM. Dis Markers (1998) 14:135-41. doi:10.1155/1998/705857
28. Sang YM, Yan C, Zhu C, Ni GC, Hu YM. [Association of human leukocyte antigen non-classical genes with type 1 diabetes]. Zhonghua Er Ke Za Zhi (2003) 41:260-3.
29. Siegmund T, Donner H, Braun J, Usadel KH, Badenhoop K. HLA-DMA and HLA-DMB alleles in German patients with type 1 diabetes mellitus. Tissue Antigens (1999) 54:291-4. doi:10.1034/j.1399-0039.1999.540313.x
30. Silva DG, Socha L, Correcha M, Petrovsky N. Elevated lymphocyte expression of CLIP is associated with type 1 diabetes and may be a useful marker of autoimmune susceptibility. Ann N Y Acad Sci (2004) 1037:65-8. doi:10.1196/annals.1337.009
31. Bhatnagar A, Milburn PJ, Lobigs M, Blanden RV, Gautam AM. Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface. J Immunol (2001) 166:4490-7.
32. Busch R, De Riva A, Hadjinicolaou AV, Jiang W, Hou T, Mellins ED. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes. Expert Rev Mol Med (2012) 14:e15. doi:10.1017/erm.2012.9
33. Hou T, Macmillan H, Chen Z, Keech CL, Jin X, Sidney J, et al. An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations. J Immunol (2011) 187:2442-52. doi:10.4049/jimmunol.1100255
34. Mohan JF, Unanue ER. Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol (2012) 12:721-8. doi:10.1038/nri3294
35. Mellanby RJ, Koonce CH, Monti A, Phillips JM, Cooke A, Bikoff EK. Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes. J Immunol (2006) 177:7588-98.
36. Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A (2004) 101:4175-9. doi:10.1073/pnas.0306885101
37. Broughton SE, Petersen J, Theodossis A, Scally SW, Loh KL, Thompson A, et al. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity (2012) 37:611-21. doi:10.1016/j.immuni.2012.07.013
38. Henderson KN, Tye-Din JA, Reid HH, Chen Z, Borg NA, Beissbarth T, et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity (2007) 27:23-34. doi:10.1016/j.immuni.2007.05.015
39. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol (2001) 2:501-7. doi:10.1038/88694
40. Tollefsen S, Hotta K, Chen X, Simonsen B, Swaminathan K, Mathews II, et al. Structural and functional studies of trans-encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) protein molecule. J Biol Chem (2012) 287:13611-9. doi:10.1074/jbc.M111.320374
41. Sethi DK, Schubert DA, Anders AK, Heroux A, Bonsor DA, Thomas CP, et al. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J Exp Med (2011) 208:91-102. doi:10.1084/jem.20100725
42. Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, Svejgaard A, et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A (2004) 101:1999-2004. doi:10.1073/pnas.0308458100
43. Painter CA, Negroni MP, Kellersberger KA, Zavala-Ruiz Z, Evans JE, Stern LJ. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Proc Natl Acad Sci U S A (2011) 108:19329-34. doi:10.1073/pnas.1108074108
44. Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, et al. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 5:381-8. doi:10.1038/sj.gene.6364106
45. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol (1997) 53:1-11. doi:10.1016/S0198-8859(97)00024-4
46. Kooy-Winkelaar Y, van Lummel M, Moustakas AK, Schweizer J, Mearin ML, Mulder CJ, et al. Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2alpha/DQ8beta transdimer. J Immunol (2011) 187:5123-9. doi:10.4049/jimmunol.1101179
47. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol (2005) 5:772-82. doi:10.1038/nri1707
48. Mathis D, Benoist C. Aire. Annu Rev Immunol (2009) 27:287-312. doi:10.1146/annurev.immunol.25.022106.141532
49. Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med (2012) 2:a007781. doi:10.1101/cshperspect.a007781
50. Sewell AK. Why must T cells be cross-reactive? Nat Rev Immunol (2012) 12:669-77. doi:10.1038/nri3279
51. Fung-Leung WP, Surh CD, Liljedahl M, Pang J, Leturcq D, Peterson PA, et al. Antigen presentation and T cell development in H2-M-deficient mice. Science (1996) 271:1278-81. doi:10.1126/science.271.5253.1278